4.8 Article

Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities

Related references

Note: Only part of the references are listed.
Article Oncology

Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor

Santhosh A. Upadhyaya et al.

Summary: This study examines the use of Aurora kinase A inhibitor alisertib in children with recurrent AT/RT. The results show that alisertib is well tolerated in children with recurrent AT/RT, and approximately one-third of the patients observed stable disease or partial response.

NEURO-ONCOLOGY (2023)

Article Clinical Neurology

ATRT-SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance

Aniello Federico et al.

Summary: Atypical teratoid/rhabdoid tumor (ATRT) is an aggressive central nervous system tumor that can be divided into three subgroups based on molecular characteristics. These subgroups show differences in age of onset, tumor location, and molecular profiles, and these differences may have biological and clinical importance.

ACTA NEUROPATHOLOGICA (2022)

Article Oncology

Infants and Newborns with Atypical Teratoid Rhabdoid Tumors (ATRT) and Extracranial Malignant Rhabdoid Tumors (eMRT) in the EU-RHAB Registry: A Unique and Challenging Population

Karolina Nemes et al.

Summary: Malignant rhabdoid tumors (MRT) predominantly affect infants and young children. A retrospective study was conducted to assess the prognostic factors, genetics, toxicity of treatment and long-term outcomes of MRT. The study found that female sex, localized stage, absence of a GLM, and maintenance therapy were significant predictors of a favorable prognosis in infants with MRT.

CANCERS (2022)

Article Medicine, Research & Experimental

Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes

Michael T. Meister et al.

Summary: This study successfully generated a collection of 19 pediatric RMS tumor organoid models, including all major subtypes. For aggressive tumors, the models can be established within a relatively short period of time and utilized for personalized drug screening. The models closely resemble the original tumors and maintain genetic stability over extended culture periods.

EMBO MOLECULAR MEDICINE (2022)

Letter Biochemistry & Molecular Biology

Mutations of MSH5 in nonobstructive azoospermia (NOA) and rescued via in vivo gene editing

Min Chen et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Oncology

Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials

Santhosh A. Upadhyaya et al.

Summary: Based on DNA methylation profiling, infants with ATRT-TYR had the best overall survival, while ATRT-SHH was associated with metastases and consequently worse outcomes. Children with nonmetastatic ATRT benefited from postoperative CSI and adjuvant chemotherapy.

CLINICAL CANCER RESEARCH (2021)

Article Cell Biology

Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors

Camilla Calandrini et al.

Summary: This study demonstrates that drug screening using organoids can identify therapeutic vulnerabilities in MRT and proposes neddylation inhibition as a potential treatment strategy. Mechanistic studies and in vivo experiments confirm the therapeutic efficacy of MLN4924 for MRT, suggesting a new direction for targeted therapy in this aggressive childhood malignancy.

CELL REPORTS (2021)

Article Biochemistry & Molecular Biology

Calling differentially methylated regions from whole genome bisulphite sequencing with DMRcate

Timothy J. Peters et al.

Summary: Whole genome bisulphite sequencing (WGBS) allows for genome-wide study of single molecule methylation patterns. The study aims to locate differential methylation patterns across the genome using statistical methods, data simulation, and benchmarking. DMRcate is found to be the fastest and the best predictor of DMRs among the methods compared in the study.

NUCLEIC ACIDS RESEARCH (2021)

Article Multidisciplinary Sciences

The repertoire of mutational signatures in human cancer

Ludmil B. Alexandrov et al.

NATURE (2020)

Article Multidisciplinary Sciences

An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity

Camilla Calandrini et al.

NATURE COMMUNICATIONS (2020)

Article Clinical Neurology

Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource

Kyle S. Smith et al.

ACTA NEUROPATHOLOGICA (2020)

Article Biotechnology & Applied Microbiology

SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events

Erik N. Bergstrom et al.

BMC GENOMICS (2019)

Article Genetics & Heredity

The mutational footprints of cancer therapies

Oriol Pich et al.

NATURE GENETICS (2019)

Article Biochemistry & Molecular Biology

A rectal cancer organoid platform to study individual responses to chemoradiation

Karuna Ganesh et al.

NATURE MEDICINE (2019)

Review Oncology

Organoids in cancer research

Jarno Drost et al.

NATURE REVIEWS CANCER (2018)

Article Multidisciplinary Sciences

Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development

Jeremie Vitte et al.

NATURE COMMUNICATIONS (2017)

Article Biochemical Research Methods

missMethyl: an R package for analyzing data from Illumina's HumanMethylation450 platform

Belinda Phipson et al.

BIOINFORMATICS (2016)

Article Biochemical Research Methods

Complex heatmaps reveal patterns and correlations in multidimensional genomic data

Zuguang Gu et al.

BIOINFORMATICS (2016)

Article Multidisciplinary Sciences

Tissue-specific mutation accumulation in human adult stem cells during life

Francis Blokzijl et al.

NATURE (2016)

Article Biochemical Research Methods

CONSERTING: integrating copy-number analysis with structural-variation detection

Xiang Chen et al.

NATURE METHODS (2015)

Article Medicine, General & Internal

Germline Mutations in Predisposition Genes in Pediatric Cancer

Jinghui Zhang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Biochemistry & Molecular Biology

limma powers differential expression analyses for RNA-sequencing and microarray studies

Matthew E. Ritchie et al.

NUCLEIC ACIDS RESEARCH (2015)

Article Multidisciplinary Sciences

Dose-Response Analysis Using R

Christian Ritz et al.

PLOS ONE (2015)

Article Biochemical Research Methods

STAR: ultrafast universal RNA-seq aligner

Alexander Dobin et al.

BIOINFORMATICS (2013)

Article Biochemistry & Molecular Biology

Low-level processing of Illumina Infinium DNA Methylation BeadArrays

Timothy J. Triche et al.

NUCLEIC ACIDS RESEARCH (2013)

Article Biochemical Research Methods

RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome

Bo Li et al.

BMC BIOINFORMATICS (2011)

Article Biochemical Research Methods

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

Mark D. Robinson et al.

BIOINFORMATICS (2010)

Article Biotechnology & Applied Microbiology

NetPath: a public resource of curated signal transduction pathways

Kumaran Kandasamy et al.

GENOME BIOLOGY (2010)